AdVEGF165 gene transfer increases surviral in overdimensioned skin flaps

Journal of Gene Medicine

Volumn 7, Issue 3, 2005, Pages 297-306

  Giunta, R E ^a   Holzbach, T ^a   Taskov, C ^a   Holm, P S ^b   Konerding, M A ^d   Schams, D ^c   Biemer, E ^a   Gansbacher B ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c University of Technology   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adenovirus; Angiogenesis; Gene therapy; Gene transfer; Skin flap; VEGF

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; INDOCYANINE GREEN; VASCULOTROPIN; CD31 ANTIGEN; COLORING AGENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG EFFICACY; FLUOROSCOPY; GENE TRANSFER; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP SURVIVAL; SKIN NECROSIS; STATISTICAL SIGNIFICANCE; TISSUE PERFUSION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; CELL SURVIVAL; CYTOLOGY; EPITHELIUM CELL; GENE VECTOR; GENETICS; HUMAN; METABOLISM; PLASTIC SURGERY; RANDOMIZATION; SKIN; SPRAGUE DAWLEY RAT; VASCULARIZATION; WOUND HEALING;

ADENOVIRIDAE; ANIMALIA;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD31; CELL SURVIVAL; COLORING AGENTS; EPITHELIAL CELLS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INDOCYANINE GREEN; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SURGICAL FLAPS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 15944376944     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.675     Document Type: Article

References (33)

1. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
2. Ylä-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701.
3. Ylä-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-222.
4. Makinen K, Manninen H, Hedman M, et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002; 6: 127-133.
5. Rajagopalan S, Mohler ER III, Lederman RJ, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003; 108: 1933-1938.
6. Hedman M, Hartikainen J, Syvanne M, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677-2683.
7. Isner JM. Myocardial gene therapy. Nature 2002; 415 234-239.
8. Rajagopalan S, Shah M, Luciano A, Crystal R, Nabel EG. Adenovirus-mediated gene transfer of VEGF (121) improves lower-extremity endothelial function and flow reserve. Circulation 2001; 104: 753-755.
9. O'Toole G, MacKenzie D, Lindeman R, et al. Vascular endothelial growth factor gene therapy in ischemic rat skin flaps. Br J Plast Surg 2002; 55: 55-58.
10. Milton SH. Pedicled skin-flaps: the fallacy of the length: width ratio. Br J Plast Surg 1970; 57: 502-508.
11. McGregor IA, Morgan G. Axial and random pattern flaps. Br J Plast Surg 1973; 26: 202-213.
12. Seify H, Bulky U, Jones G. Effect of vascular endothelial growth factor-induced angiogenesis on TRAM flap harvesting after adominoplasty. Plast Reconstr Surg 2003; 111: 1212-1216.
13. Zhang F, Fischer K, Komorowska-Timek E, et al. Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model. Ann Plast Surg 2001; 46: 314-319.
14. Zhang F, Oswald T, Lin S, et al. Vascular endothelial growth factor (VEGF) expression and the effect of exogenous VEGF on survival of a random flap in the rat. Br J Plast Surg 2003; 56 653-659.
15. Li QF, Reis ED, Zhang WX, Silver L, Fallon JT, Weinberg H. Accelerated flap prefabrication with vascular endothelial growth factor. J Reconstr Microsurg 2000; 16: 45-49.
16. Kryger Z, Dogan T, Zhang F, et al. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg 1999; 43: 172-178.
17. Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, Buncke HJ. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 2000; 53: 234-239.
18. Padubidri A, Browne E Jr. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 1996; 37: 604-611.
19. Taub PJ, Marmur JD, Zhang WX, et al. Locally administered vascular endothelial groth factor cDNA increases survival of ischemic experimental skin flaps. Plast Reconstr Surg 1998; 102 2003-2039.
20. Wang F, Zhao M, Huang B, et al. Subcutaneous injection of plasmid VEGF gene: a method of gene therapy to enhance the viability of random skin flap. Zhonghua Zheng Xing Wai Ke Za Zhi 2002; 18 157-159.
21. Neumeister MW, Song YH, Mowlavi A, Suchy H, Mathur A. Effects of liposome-mediated gene transfer of VEGF in ischemic rat gracilis muscle. Microsurgery 2001; 21: 58-62.
22. Liu Py, Tong W, Liu K, et al. Liposome-mediated transfer of vascular endothelial growth factor cDNA augments survival of random-pattern skin flaps in the rat. Wound Repair Regen 2004; 12: 80-85.
23. Cui L, Li FC, Zhang Q, Qian YL, Guan WX. Effect of adenovirus-mediated gene transfection of vascular endothelial growth factor on survival of random flaps in rats. Chin J Traumatol 2003; 6: 199-204.
24. Gurunluoglu R, Ozer K, Skugor B, Lubiatowski P, Carnevale K, Siemionow M. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene. Ann Plast Surg 2002; 49: 161-169.
25. Lubiatowski P, Goldman CK, Gurunluoglu R, Carnevale K, Semionow M. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 2002; 109: 1986-1993.
26. Magovern CJ, Mack C, Zhang J, Rosengart TK, Isom OW, Crystal RG. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum Gene Ther 1997; 20: 215-227.
27. Holm PS, Bergmann S, Jurchott K, et al. YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter. J Biol Chem 2002; 277: 10 427-10 434.
28. Holm PS, Lage H, Bergmann S, et al. Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy. Cancer Res 2004; 64: 322-328.
29. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R. Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biol Reproduct 2000; 63: 1106-1114.
30. Chalkley H. Method for the quantitative morphological analysis of tissues. J Natl Cancer Inst 1943; 4: 47-53.
31. Li C, Gardy R, Seon BK, et al. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer 2003; 88: 1424-1431.
32. Marcus R, Peritz E, Gabriel KR. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63: 655-660.
33. Ashrafpour H, Huang, N, Neligan PC, et al. Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature. Am J Physiol Heart Circ Physiol 2004; 286: 946-954.